What the studies show
No effect on BMI, fasting insulin or HOMA-IR; a small fall in total cholesterol.
“No significant effects were observed on body mass index (BMI), fasting insulin. low-density lipoprotein cholesterol (LDL-c) or high-density lipoprotein cholesterol (HDL-c), but a lowering effect was observed in total cholesterol (TC).”
A few small or poorly-controlled human studies. Enough to be interesting; not enough to count on. Most of what gets called “clinically proven” online lives here.
- 1Li N, et al. Effect of carnosine or beta-alanine supplementation therapy for prediabetes or type 2 diabetes mellitus: a systematic review and meta-analysis of randomized controlled trials.BMC Endocr Disord, 20258 trials, 377 participants.
In context
Carnosine is a dipeptide of beta-alanine and histidine concentrated in muscle and brain, sold as a supplement for glucose control, ageing and exercise. A 2025 meta-analysis of eight randomised trials in 377 people with prediabetes or type 2 diabetes found modest reductions in fasting glucose and HbA1c against placebo, with no effect on weight or insulin resistance. The trials are small and short, and oral carnosine is largely broken down in blood before it reaches tissue. It is a food supplement, not a medicine.
Carnosine is food supplement. Legal status differs by country — see the regulation section or the jurisdiction pages.
Questions
Is Carnosine proven to help with body weight and insulin resistance?
What studies are behind the grade?
Is Carnosine approved for this?
Other outcomes for Carnosine
- CBlood glucose (fasting glucose and HbA1c) in prediabetes and type 2 diabetes8 RCTs (n=377) pooled
- DCognition or ageingNo adequate trial
Written and maintained by LYO Research — how pages are written and checked. Reviewed 23 September 2026. Grades count human evidence only; see how LYO grades. Not medical advice. Correct this page →